Terms: = Prostate cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA
48 results:
1. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
[TBL] [Abstract] [Full Text] [Related]
2. Regulation of SPDEF expression by DNA methylation in advanced prostate cancer.
Vatanmakanian M; Steffan JJ; Koul S; Ochoa AC; Chaturvedi LS; Koul HK
Front Endocrinol (Lausanne); 2023; 14():1156120. PubMed ID: 37900138
[TBL] [Abstract] [Full Text] [Related]
3. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
4. Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and prostate cancer Cell Growth.
Cho CC; Lin CJ; Huang HH; Yang WZ; Fei CY; Lin HY; Lee MS; Yuan HS
ACS Chem Biol; 2023 Jun; 18(6):1335-1350. PubMed ID: 37188336
[TBL] [Abstract] [Full Text] [Related]
5. Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients.
Liang Y; Chiu PK; Zhu Y; Wong CY; Xiong Q; Wang L; Teoh JY; Cao Q; Wei Y; Ye DW; Tsui SK; Ng CF
PLoS Genet; 2022 Sep; 18(9):e1010373. PubMed ID: 36095024
[TBL] [Abstract] [Full Text] [Related]
6. Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer.
Wang C; Leavenworth J; Zhang C; Liu Z; Yuan KY; Wang Y; Zhang G; Wang S; Cui X; Zhang Y; Bae S; Zhou J; Wang L; Liu R
Oncogene; 2022 May; 41(19):2778-2785. PubMed ID: 35361883
[TBL] [Abstract] [Full Text] [Related]
7. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.
Nicolae A; Bouilly J; Lara D; Fataccioli V; Lemonnier F; Drieux F; Parrens M; Robe C; Poullot E; Bisig B; Bossard C; Letourneau A; Missiaglia E; Bonnet C; Szablewski V; Traverse-Glehen A; Delfau-Larue MH; de Leval L; Gaulard P
Mod Pathol; 2022 Aug; 35(8):1126-1136. PubMed ID: 35301414
[TBL] [Abstract] [Full Text] [Related]
8. Targeting DNMTs to Overcome Enzalutamide Resistance in prostate cancer.
Farah E; Zhang Z; Utturkar SM; Liu J; Ratliff TL; Liu X
Mol Cancer Ther; 2022 Jan; 21(1):193-205. PubMed ID: 34728570
[TBL] [Abstract] [Full Text] [Related]
9. dnmt3a epigenetically regulates key microRNAs involved in epithelial-to-mesenchymal transition in prostate cancer.
Mancini M; Grasso M; Muccillo L; Babbio F; Precazzini F; Castiglioni I; Zanetti V; Rizzo F; Pistore C; De Marino MG; Zocchi M; Del Vescovo V; Licursi V; Giurato G; Weisz A; Chiarugi P; Sabatino L; Denti MA; Bonapace IM
Carcinogenesis; 2021 Dec; 42(12):1449-1460. PubMed ID: 34687205
[TBL] [Abstract] [Full Text] [Related]
10. Out-of-pocket costs for commercially insured patients with localized prostate cancer.
Wallis CJD; Joyce DD; Klaassen Z; Luckenbaugh AN; Laviana AA; Penson D; Dusetzina SB; Barocas DA
Urol Oncol; 2021 Dec; 39(12):797-805. PubMed ID: 34600803
[TBL] [Abstract] [Full Text] [Related]
11. Co-Targeting Plk1 and dnmt3a in Advanced prostate cancer.
Zhang Z; Cheng L; Zhang Q; Kong Y; He D; Li K; Rea M; Wang J; Wang R; Liu J; Li Z; Yuan C; Liu E; Fondufe-Mittendorf YN; Li L; Han T; Wang C; Liu X
Adv Sci (Weinh); 2021 Jul; 8(13):e2101458. PubMed ID: 34051063
[TBL] [Abstract] [Full Text] [Related]
12. Upregulated PPARG2 facilitates interaction with demethylated AKAP12 gene promoter and suppresses proliferation in prostate cancer.
Li F; Lu T; Liu D; Zhang C; Zhang Y; Dong F
Cell Death Dis; 2021 May; 12(6):528. PubMed ID: 34023860
[TBL] [Abstract] [Full Text] [Related]
13. SChLAP1 promotes prostate cancer development through interacting with EZH2 to mediate promoter methylation modification of multiple miRNAs of chromosome 5 with a dnmt3a-feedback loop.
Huang K; Tang Y
Cell Death Dis; 2021 Feb; 12(2):188. PubMed ID: 33589600
[TBL] [Abstract] [Full Text] [Related]
14. Investigation of GSTP1 and epigenetic regulators expression pattern in a population of Iranian patients with prostate cancer.
Mohammadi M; Irani S; Salahshourifar I; Hosseini J; Moradi A; Pouresmaeili F
Hum Antibodies; 2020; 28(4):327-334. PubMed ID: 32831196
[TBL] [Abstract] [Full Text] [Related]
15. Expression of UDP Glucuronosyltransferases
Shafiee-Kermani F; Carney ST; Jima D; Utin UC; Farrar LB; Oputa MO; Hines MR; Kinyamu HK; Trotter KW; Archer TK; Hoyo C; Koller BH; Freedland SJ; Grant DJ
Epigenetics; 2021 Mar; 16(3):289-299. PubMed ID: 32660355
[TBL] [Abstract] [Full Text] [Related]
16. Curcumin stimulates angiogenesis through VEGF and expression of HLA-G in first-trimester human placental trophoblasts.
Basak S; Srinivas V; Mallepogu A; Duttaroy AK
Cell Biol Int; 2020 May; 44(5):1237-1251. PubMed ID: 32073198
[TBL] [Abstract] [Full Text] [Related]
17. Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progression.
Tzelepi V; Logotheti S; Efstathiou E; Troncoso P; Aparicio A; Sakellakis M; Hoang A; Perimenis P; Melachrinou M; Logothetis C; Zolota V
Pathology; 2020 Feb; 52(2):218-227. PubMed ID: 31864524
[TBL] [Abstract] [Full Text] [Related]
18. Specific zinc finger-induced methylation of PD-L1 promoter inhibits its expression.
Li X; Wang Z; Huang J; Luo H; Zhu S; Yi H; Zheng L; Hu B; Yu L; Li L; Xie J; Zhu N
FEBS Open Bio; 2019 Jun; 9(6):1063-1070. PubMed ID: 31090214
[TBL] [Abstract] [Full Text] [Related]
19. Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells.
Zwergel C; Schnekenburger M; Sarno F; Battistelli C; Manara MC; Stazi G; Mazzone R; Fioravanti R; Gros C; Ausseil F; Florean C; Nebbioso A; Strippoli R; Ushijima T; Scotlandi K; Tripodi M; Arimondo PB; Altucci L; Diederich M; Mai A; Valente S
Clin Epigenetics; 2019 May; 11(1):68. PubMed ID: 31060628
[TBL] [Abstract] [Full Text] [Related]
20. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
[TBL] [Abstract] [Full Text] [Related]
[Next]
